RS&H provided architectural and laboratory programming, planning, and design services for this four-story, 100,000-square-foot cancer research building designed to enable M2Gen to develop personalized cancer treatments for patients using advanced molecular technology. As a partnership between Moffit Cancer Research and Merck & Co., M2Gen researchers will collect tumor tissues from thousands of patients and identify the biological markers unique to each tumor. Analyzing a patient’s response to specific treatments will lead to more individualized care aimed at providing rapid improvement with fewer side effects, taking Moffitt Cancer Research Institute’s wide-ranging initiative to a new level.
The project scope includes the initial research building and site work with potential future phases for additional significant research buildings on the new Moffitt McKinley Campus in Tampa. The two primary activities at the M2Gen facility are bio-repository functions (tissue processing and tissue banking) and data archiving and analytic functions (IT, informatics, etc.).
Laboratories include sample receipt and shipping, histology, macrodissection, coding, staining, paraffin block storage, microscopy suites, and cryotomy laboratories. The building also includes cryogenic storage facilities.
Moffitt Cancer Research Institute/Merck & Co., Tampa, Florida
100,000 Gross Square Feet